Osteoporosis Management in a Medicaid Population after the Women's Health Initiative Study-Reference-Cited by-同舟云学术

Osteoporosis Management in a Medicaid Population after the Women's Health Initiative Study

Published:2006-03 Issue:2 Volume:15 Page:155-161
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Lee Euni¹,Wutoh Anthony K.¹,Xue Zhenyi¹²,Hillman Jennifer J.²,Zuckerman Ilene H.³

Affiliation:

1. Center for Minority Health Services Research, Department of Clinical and Administrative Pharmacy Sciences, School of Pharmacy, Howard University, Washington, DC.

2. McKesson Medication Management, McAllen Medical Center, McAllen, Texas.

3. The Peter Lamy Center on Drug Therapy and Aging, Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jwh.2006.15.155

Reference16 articles.

1. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2. American Association of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, With Selected Updates For 2003

3. The Impact of the Women's Health Initiative on Hormone Replacement Therapy in a Medicaid Program

4. Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women’s Health Initiative

5. Using data from automated dispensing units to identify adverse drug reactions

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global burden of hip fracture: The Global Burden of Disease Study;Osteoporosis International;2023-09-14

2. Trends in Prescribing Menopausal Hormone Therapy and Bisphosphonates in Australia and Manitoba, Canada and Adherence to Recommendations;Journal of Women's Health;2020-02-01

3. Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication;Saudi Pharmaceutical Journal;2018-02

4. Hip fracture trends in the United States, 2002 to 2015;Osteoporosis International;2017-12-27

5. Medicaid osteoporosis drugs utilization and expenditures: the effect of generic drugs market entry;Journal of Pharmaceutical Health Services Research;2016-06-09